This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Limouzin-Lamothe MA, Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 1994; 170: 618-24.10.1016/S0002-9378(94)70239-X7509570Limouzin-LamotheMAMaironNJoyceCRLe GalM.Quality of life after the menopause: influence of hormonal replacement therapyAm J Obstet Gynecol.199417061824Open DOISearch in Google Scholar
Panichkul S, Wongwannanuruk T, Boonyanuruk P, Wiriyasirivaj B, Wanichsetakul P, Pongsatha S, et al. Menopause-related symptoms and quality of life in peri- and postmenopausal women in Thailand: a multicenter study. Asian Biomed. 2017; 11: 207-16.PanichkulSWongwannanurukTBoonyanurukPWiriyasirivajBWanichsetakulPPongsathaSMenopause-related symptoms and quality of life in peri- and postmenopausal women in Thailand: a multicenter studyAsian Biomed.20171120716Search in Google Scholar
Martin KA, Barbieri RL. Menopausal hormone therapy: Benefits and risks. In: Snyder PJ, Crowley WF, Jr, Martin KA (editors), UpToDate, Waltham, MA: Wolters Kluwer [online] 2017 [cited 2017 June 14]. Available from: http://www.uptodate.comMartinKABarbieriRL.Menopausal hormone therapy: Benefits and risksSnyderPJCrowleyWF JrMartinKA.UpToDateWaltham, MAWolters Kluwer[online] 2017 [cited 2017 June 14]. Available fromhttp://www.uptodate.comSearch in Google Scholar
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288:321-33.10.1001/jama.288.3.32112117397RossouwJEAndersonGLPrenticeRLLaCroixAZKooperbergCStefanickMLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA.20022883213312117397Open DOISearch in Google Scholar
Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab. 2011; 96: 255-64.2129698910.1210/jc.2010-0536TaylorHSMansonJE.Update in hormone therapy use in menopauseJ Clin Endocrinol Metab.2011962556421296989Search in Google Scholar
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013; 310:1353-68.10.1001/jama.2013.27804024084921MansonJEChlebowskiRTStefanickMLAragakiAKRossouwJEPrenticeRLMenopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trialsJAMA.2013310135368396352324084921Open DOISearch in Google Scholar
Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100: 3975-4011.10.1210/jc.2015-223626444994StuenkelCADavisSRGompelALumsdenMAMuradMHPinkertonJVTreatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice GuidelineJ Clin Endocrinol Metab.20151003975401126444994Open DOISearch in Google Scholar
Management of menopausal symptoms. Practice Bulletin No. 141. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2014; 123:202-16.24463691Management of menopausal symptoms. Practice Bulletin No. 141. American College of Obstetricians and GynecologistsObstet Gynecol.20141232021610.1097/01.AOG.0000441353.20693.7824463691Search in Google Scholar
